{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:24:23Z","timestamp":1772119463584,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,11,19]],"date-time":"2011-11-19T00:00:00Z","timestamp":1321660800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s10238-011-0164-3","type":"journal-article","created":{"date-parts":[[2011,11,18]],"date-time":"2011-11-18T07:47:12Z","timestamp":1321602432000},"page":"241-245","source":"Crossref","is-referenced-by-count":16,"title":["Recombinant human interferon gamma (Gamma Immunex) in treatment of atopic dermatitis"],"prefix":"10.1007","volume":"12","author":[{"given":"Yunes","family":"Panahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyyed Masoud","family":"Davoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Madanchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Abolhasani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,19]]},"reference":[{"issue":"2","key":"164_CR1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amjmed.2008.09.014","volume":"122","author":"N Wasserbauer","year":"2010","unstructured":"Wasserbauer N, Ballow M (2010) Atopic dermatitis. Am J Med 122(2):121\u2013125","journal-title":"Am J Med"},{"key":"164_CR2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00403-006-0657-1","volume":"298","author":"YC Dou","year":"2006","unstructured":"Dou YC, Hagstromer L, Emtestam L, Johansson O (2006) Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study. Arch Dermatol Res 298:31\u201337","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"164_CR3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10227-003-0164-3","volume":"7","author":"SM Herman","year":"2003","unstructured":"Herman SM, Vender RB (2003) Antihistamines in the treatment of dermatitis. J Cutan Med Surg 7(6):467\u2013473","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"164_CR4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1529-8019.2009.01295.x","volume":"23","author":"V Broshtilova","year":"2010","unstructured":"Broshtilova V, Gantcheva M (2010) Therapeutic hotline: cysteinyl leukotriene receptor antagonist montelukast in the treatment of atopic dermatitis. Dermatol Ther 23(1):90\u201393","journal-title":"Dermatol Ther"},{"issue":"1","key":"164_CR5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5021\/ad.2010.22.1.9","volume":"22","author":"S Haw","year":"2010","unstructured":"Haw S, Shin MK, Haw CR (2010) The efficacy and safety of long-term oral cyclosporine treatment for patients with atopic dermatitis. Ann Dermatol 22(1):9\u201315","journal-title":"Ann Dermatol"},{"issue":"6","key":"164_CR6","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1365-2230.2008.02832.x","volume":"33","author":"R Hughes","year":"2008","unstructured":"Hughes R, Collins P, Rogers S (2008) Further experience of using azathioprine in the treatment of severe atopic dermatitis. Clin Exp Dermatol 33(6):710\u2013711","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"164_CR7","first-page":"23","volume":"32","author":"ML Murray","year":"2007","unstructured":"Murray ML, Cohen JB (2007) Mycophenolate mofetil therapy for moderate to severe atopic dermatitis. Clin Exp Dermatol 32(1):23\u201327","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"164_CR8","first-page":"488","volume":"9","author":"AB Fleischer Jr","year":"2010","unstructured":"Fleischer AB Jr, Boguniewicz M (2010) An approach to pruritus in atopic dermatitis: a critical systematic review of the tacrolimus ointment literature. J Drugs Dermatol 9(5):488\u2013498","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"164_CR9","first-page":"499","volume":"92","author":"J Musia\u0142","year":"1994","unstructured":"Musia\u0142 J, Milewski M, Undas A, Kopi\u0144ski P, Duplaga M, Szczeklik A (1994) Human recombinant interferon gamma in the treatment of atopic dermatitis. Pol Arch Med Wewn 92(6):499\u2013506","journal-title":"Pol Arch Med Wewn"},{"issue":"6","key":"164_CR10","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1067\/mjd.2000.104793","volume":"42","author":"IG Jang","year":"2000","unstructured":"Jang IG, Yang JK, Lee HJ, Yi JY, Kim HO, Kim CW, Kim TY (2000) Clinical improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon gamma. J Am Acad Dermatol 42(6):1033\u20131040","journal-title":"J Am Acad Dermatol"},{"key":"164_CR11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0190-9622(93)70026-P","volume":"28","author":"JM Hanifin","year":"1993","unstructured":"Hanifin JM, Schneider LC, Leung DYM et al (1993) Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 28:189\u2013197","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"164_CR12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/00128071-200203030-00004","volume":"3","author":"TT Chang","year":"2002","unstructured":"Chang TT, Stevens SR (2002) Atopic dermatitis: the role of recombinant interferon-gamma therapy. Am J Clin Dermatol 3(3):175\u2013183","journal-title":"Am J Clin Dermatol"},{"key":"164_CR13","doi-asserted-by":"crossref","unstructured":"Jujo K, Renz H, Abe J, Gelfand EW, Leung DY (1992) Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J Allergy Clin Immunol 90(3 Pt 1):323\u2013331","DOI":"10.1016\/S0091-6749(05)80010-7"},{"issue":"3","key":"164_CR14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaci.2006.05.024","volume":"118","author":"Y Tenda","year":"2006","unstructured":"Tenda Y, Yamashita M, Kimura MY, Hasegawa A, Shimizu C, Kitajima M, Onodera A, Suzuki A, Seki N, Nakayama T (2006) Hyperresponsive TH2 cells with enhanced nuclear factor-kappa B activation induce atopic dermatitis-like skin lesions in Nishiki-nezumi Cinnamon\/Nagoya mice. J Allergy Clin Immunol 118(3):725\u2013733","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"164_CR15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1398-9995.1993.tb00712.x","volume":"48","author":"J Punnonen","year":"1993","unstructured":"Punnonen J, Punnonen K, Jans\u00e9n CT, Kalimo K (1993) Interferon (IFN)-alpha, IFN-gamma, interleukin (IL)-2, and arachidonic acid metabolites modulate IL-4-induced IgE synthesis similarly in healthy persons and in atopic dermatitis patients. Allergy 48(3):189\u2013195","journal-title":"Allergy"},{"key":"164_CR16","unstructured":"Gruner S, Liebenthal C, Heusser C, Brinkmann V, Zwirner A, Reinicke C, Harnack K, S\u00f6nnichsen N, Volk HD (1991) The influence of interferon-gamma and interleukin-4 on IgE production in B lymphocytes of patients with atopic dermatitis. A possible criterion for selection of patients for interferon therapy. Acta Derm Venereol 71(6):484\u2013487"},{"issue":"6","key":"164_CR17","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1523-1747.1998.00454.x","volume":"111","author":"A Sato","year":"1998","unstructured":"Sato A, Tsuji K, Yamamura M, Morita Y, Kanzaki H, Tada J, Makino H, Arata J (1998) Increased type 2 cytokine expression by both CD4\u00a0+\u00a0CD45RO\u00a0+\u00a0T cells and CD8\u00a0+\u00a0CD45RO\u00a0+\u00a0T cells in blood circulation is associated with high serum IgE but not with atopic dermatitis. J Invest Dermatol 111(6):1079\u20131084","journal-title":"J Invest Dermatol"},{"issue":"1","key":"164_CR18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-3164.2010.00897.x","volume":"22","author":"S Shibata","year":"2011","unstructured":"Shibata S, Maeda S, Kondo N, Inoue A, Maeda S, Chimura N, Fukata T (2011) Effect of recombinant canine interferon-\u03b3 on granulocyte-macrophage colony-stimulating factor, transforming growth factor-\u03b2 and CC chemokine ligand 17 mRNA transcription in a canine keratinocyte cell line (CPEK). Vet Dermatol 22(1):24\u201330","journal-title":"Vet Dermatol"},{"issue":"5","key":"164_CR19","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.4049\/jimmunol.0900215","volume":"184","author":"K Hattori","year":"2010","unstructured":"Hattori K, Nishikawa M, Watcharanurak K, Ikoma A, Kabashima K, Toyota H, Takahashi Y, Takahashi R, Watanabe Y, Takakura Y (2010) Sustained exogenous expression of therapeutic levels of IFN-gamma ameliorates atopic dermatitis in NC\/Nga mice via Th1 polarization. J Immunol 184(5):2729\u20132735","journal-title":"J Immunol"},{"issue":"1","key":"164_CR20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0190-9622(93)70152-J","volume":"29","author":"U Reinhold","year":"1993","unstructured":"Reinhold U, Kukel S, Brzoska J, Kreysel HW (1993) Systemic interferon gamma treatment in severe atopic dermatitis. J Am Acad Dermatol 29(1):58\u201363","journal-title":"J Am Acad Dermatol"},{"key":"164_CR21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2133.1994.tb08530.x","volume":"131","author":"HC Williams","year":"1994","unstructured":"Williams HC, Burney PG, Hay RJ, Archer CB, Shipley MJ, Hunter JJ (1994) The U.K. working party\u00b4s diagnostic criteria for atopic dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 131:383\u2013396","journal-title":"Br J Dermatol"},{"key":"164_CR22","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2133.1994.tb08532.x","volume":"131","author":"HC Williams","year":"1994","unstructured":"Williams HC, Burney PGJ, Pembroke AC, Hay RJ (1994) The UK working party\u2019s diagnostic criteria for atopic dermatitis III: Independent hospital validation. Br J Dermatol 131:406\u2013416","journal-title":"Br J Dermatol"},{"key":"164_CR23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2133.1994.tb08531.x","volume":"131","author":"HC Williams","year":"1994","unstructured":"Williams HC, Burney PGJ, Strachan D, Hay RJ (1994) The UK working party\u2019s diagnostic criteria for atopic dermatitis II: observer variation of clinical diagnosis and signs of atopic dermatitis. Br J Dermatol 131:397\u2013405","journal-title":"Br J Dermatol"},{"key":"164_CR24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0002-9343(90)90490-5","volume":"88","author":"M Boguniewicz","year":"1990","unstructured":"Boguniewicz M, Jaffe HS, Izu A et al (1990) Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels. Am J Med 88:365\u2013370","journal-title":"Am J Med"},{"key":"164_CR25","unstructured":"Costa C, Rilliet A, Nicolet M, Saurat JH (1989) Scoring atopic dermatitis. The simpler the better? Acta Derm Venereol(Stockh) 69:41\u201345"},{"key":"164_CR26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2133.2007.08112.x","volume":"157","author":"AP Oranje","year":"2007","unstructured":"Oranje AP, Glazenburg EJ, Wolkerstorfer A, De Waard-Van Der Spek FB (2007) Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score. Br J Dermatol 157:645\u2013648","journal-title":"Br J Dermatol"},{"key":"164_CR27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"A Finlay","year":"1994","unstructured":"Finlay A, Khan G (1994) Dermatology life quality index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 19:210\u2013216","journal-title":"Clin Exp Dermatol"},{"key":"164_CR28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1081-1206(10)62968-7","volume":"80","author":"LC Schneider","year":"1998","unstructured":"Schneider LC, Baz Z, Zarcone C, Zurakowski D (1998) Long term therapy with recombinant interferon-gamma for atopic dermatitis. Ann Allergy Asthma Immunol 80:263\u2013268","journal-title":"Ann Allergy Asthma Immunol"},{"key":"164_CR29","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/archderm.134.7.799","volume":"134","author":"SR Steven","year":"1998","unstructured":"Steven SR, Hanifin JM, Hamilton T, Tofte SJ, Cooper KD (1998) Long-term effectiveness and safety of recombinant human interferon gamma therapy for atopic dermatitis despite unchanged serum IgE levels. Arch Dermatol 134:799\u2013804","journal-title":"Arch Dermatol"},{"key":"164_CR30","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1398-9995.1995.tb01190.x","volume":"50","author":"J Musial","year":"1995","unstructured":"Musial J, Milewski M, Undas A, Kopinski P, Duplaga M, Szczeklik A (1995) Interferon-gamma in treatment of atopic dermatitis: influence on T-cell activation. Allergy 50:520\u2013523","journal-title":"Allergy"},{"issue":"6","key":"164_CR31","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.0022-202X.2005.23928.x","volume":"125","author":"M Takakura","year":"2005","unstructured":"Takakura M, Takeshita F, Aihara M, Xin KQ, Ichino M, Okuda K, Ikezawa Z (2005) Hyperproduction of IFN-gamma by CpG oligodeoxynucleotide-induced exacerbation of atopic dermatitis-like skin lesion in some NC\/Nga mice. J Invest Dermatol 125(6):1156\u20131162","journal-title":"J Invest Dermatol"},{"issue":"1","key":"164_CR32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0091-6749(95)70036-6","volume":"96","author":"MR Simon","year":"1995","unstructured":"Simon MR, Cooper KD, Norris RB, Blok B, King CL (1995) Antigen presenting cell-independent cytokine and spontaneous in vitro IgE production in patients with atopic dermatitis: increased interferon-gamma production and lack of effects of in vivo low-dose interferon-gamma treatment. J Allergy Clin Immunol 96(1):84\u201391","journal-title":"J Allergy Clin Immunol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-011-0164-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-011-0164-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-011-0164-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T07:37:36Z","timestamp":1559115456000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-011-0164-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,19]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["164"],"URL":"https:\/\/doi.org\/10.1007\/s10238-011-0164-3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13465958.14846058","asserted-by":"object"}]},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,19]]}}}